Elon musk: The US Food and Drug Administration (FDA) has given Neuralink, Elon Musk's brain implant business, permission to begin its first-in-human clinical study.

Musk has predicted that his medical device company will soon begin human trials of a brain implant to treat untreatable conditions like paralysis and blindness at least four times since 2019.

However, the company, which was founded in 2016, didn't apply for FDA approval until early 2022, and when it did, the agency denied the request, seven current and former employees told Reuters in March.

Also Read: VIDEO! Suddenly dozens of people crowded at the airport, kicking and punching fiercely

The FDA's approval comes after US lawmakers urged regulators earlier this month to look into whether the composition of a panel in charge of Neuralink's animal testing played a role in the hurried and poorly executed experiments. Federal investigations have already been conducted on Neuralink.

investigating potential violations of the Animal Welfare Act, which controls how certain types of animals are used in research and tested, at the request of a federal prosecutor.

Also Read:  Grandmother made last video with granddaughter before dying, then got 'death injection' done

The investigation has also looked into how Neuralink was managed by the USDA.
Neuralink stated that the business is not currently accepting clients for clinical trials in a tweet on Thursday.

"This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people," Neuralink wrote in a tweet on Thursday.

Also Read:  13 year old girl lost her life due to social media trend, must read this news

Neuralink is working on a brain implant that it hopes will restore movement to paralysed people and treat other neurological conditions.A request for comment from Reuters was not immediately answered by the FDA.